Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorAribas, Yavuz Kemal
dc.contributor.authorAribas, Atike Burcin Tefon
dc.contributor.authorErcin, Ugur
dc.contributor.authorSarikaya, Burcu
dc.contributor.authorBilgihan, Ayse
dc.contributor.authorBilgihan, Kamil
dc.date.accessioned2023-11-16T18:30:24Z
dc.date.available2023-11-16T18:30:24Z
dc.date.issued2022
dc.identifier.issn1081-597X
dc.identifier.issn1938-2391
dc.identifier.urihttps://doi.org/10.3928/1081597X-20220906-01
dc.identifier.urihttps://hdl.handle.net/20.500.14065/5649
dc.description.abstractPURPOSE: To evaluate the biomechanical changes and ad-vanced oxidation protein products (AOPP) production after different corneal cross-linking (CXL) protocols with or with-out oxygen supplementation.METHODS: Ovine eyes in the study were equally distributed to five groups as control, standard Dresden protocol, diluted alco- hol-and iontophoresis-assisted CXL (DAI-CXL), and 0.1% and 0.2% riboflavin-mediated iontophoresis-assisted CXL with oxy-gen supplementation (I-CXL). Corneas that received CXL were divided into two equal parts, one part was used for uniaxial tensiometry and one part was used for AOPP measurement.RESULTS: All treatment groups showed higher Young's modu-lus and stiffness compared to the control group (P < .05). Both oxygen-assisted I-CXL groups with 0.1% and 0.2% riboflavin con-centrations had higher corneal Young's modulus (P = .009 and .006, respectively) and stiffness (P = .009) values, whereas the DAI-CXL group had lesser Young's modulus and stiffness values (P = .032) compared to the Dresden protocol group. All treatment groups showed higher AOPP concentrations compared to the control group (P < .05). DAI-CXL and I-CXL groups showed similar AOPP formation compared to the Dresden protocol (P = .673).CONCLUSIONS: When the epithelium is intact, the desired in-crease in corneal stiffness might not be achieved. However, increasing the oxygen in the environment might provide a suf-ficient increase in stiffness in cases undergoing epithelium-on I-CXL, which might be promising in terms of shortening the CXL therapy and decreasing the complications.en_US
dc.description.sponsorshipOENTAL (Teacher Naime Toemek Research Laboratory); Hacettepe University Bioengineering Departmenten_US
dc.description.sponsorshipThe authors thank Naime Toemek, who is the supporter of the OENTAL (Teacher Naime Toemek Research Laboratory) and the Hacettepe University Bioengineering Department.en_US
dc.language.isoengen_US
dc.publisherSlack Incen_US
dc.relation.ispartofJournal of Refractive Surgeryen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectTransepithelial Diluted Alcoholen_US
dc.subjectBiomechanical Propertiesen_US
dc.subjectRiboflavin Concentrationen_US
dc.subjectProgressive Keratoconusen_US
dc.subjectPorcine Corneasen_US
dc.subjectEpitheliumen_US
dc.subjectEfficacyen_US
dc.subjectStressen_US
dc.subjectLighten_US
dc.titleIontophoresis Corneal Cross-linking With Oxygen Supplementation in Ovine Eyesen_US
dc.typearticleen_US
dc.authoridArıbaş, Yavuz Kemal/0000-0001-5516-0747
dc.departmentUfuk Üniversitesien_US
dc.identifier.doi10.3928/1081597X-20220906-01
dc.identifier.volume38en_US
dc.identifier.issue10en_US
dc.identifier.startpage674en_US
dc.identifier.endpage681en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorwosidArıbaş, Yavuz Kemal/HPC-5846-2023
dc.identifier.wosWOS:000875668400001en_US
dc.identifier.scopus2-s2.0-85139428467en_US
dc.identifier.pmid36214347en_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster